Profile data is unavailable for this security.
About the company
Innova Captab Limited is an integrated pharmaceutical company. The Company is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It has presence across the pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes Contract Development and Manufacturing (CDMO) business, Domestic Branded Generics, and International Branded Generics product business. Its CDMO business provides research, product development and manufacturing services. Its Branded Generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. It has developed a diversified branded generics product portfolio including Tablets, dry syrups, capsules, and others.
- Revenue in INR (TTM)11.42bn
- Net income in INR1.06bn
- Incorporated2005
- Employees--
- LocationInnova Captab LtdSco-301, 2nd floor,Sector-9,PANCHKULA 134109IndiaIND
- Phone+91 1 724194500
- Websitehttp://www.innovacaptab.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd | 24.16bn | -2.48bn | 28.62bn | 1.13k | -- | -- | 165.73 | 1.18 | -15.81 | -15.81 | 154.06 | -- | -- | -- | -- | 21,344,260.00 | -- | -0.3986 | -- | -0.4888 | 79.30 | 73.83 | -10.27 | -1.54 | -- | -0.7216 | -- | -- | 8.41 | 4.91 | -414.93 | -- | -0.3175 | -- |
| SMS Pharmaceuticals Ltd | 7.38bn | 569.64m | 30.22bn | 1.20k | 52.89 | -- | 33.96 | 4.09 | 6.75 | 6.75 | 87.48 | -- | -- | -- | -- | 6,168,549.00 | -- | 5.43 | -- | 7.33 | 30.12 | 33.30 | 7.69 | 7.87 | -- | 4.21 | -- | 6.17 | 35.86 | 8.81 | 805.82 | 4.47 | 8.41 | 9.86 |
| Solara Active Pharma Sciences Ltd | 13.00bn | -5.61bn | 31.68bn | 2.16k | -- | -- | -- | 2.44 | -143.75 | -143.75 | 334.17 | -- | -- | -- | -- | 6,030,149.00 | -- | -2.44 | -- | -3.84 | 37.34 | 41.16 | -43.17 | -4.49 | -- | -1.57 | -- | -- | -10.73 | -1.45 | -2,458.12 | -- | -4.81 | -- |
| Indoco Remedies Ltd | 18.22bn | 766.90m | 34.06bn | 5.93k | 44.80 | -- | 19.56 | 1.87 | 8.25 | 8.25 | 178.33 | -- | -- | -- | -- | 3,072,462.00 | -- | 6.88 | -- | 9.85 | 68.61 | 65.59 | 4.10 | 6.93 | -- | 2.95 | -- | 14.02 | 8.91 | 13.41 | -30.78 | -- | 34.54 | 37.97 |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 34.42bn | 1.23k | -- | 108.86 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
| RPG Life Sciences Limited | 6.00bn | 923.20m | 34.94bn | 1.27k | 37.84 | -- | 31.63 | 5.83 | 55.82 | 55.82 | 362.60 | -- | -- | -- | -- | 4,721,969.00 | -- | 16.07 | -- | 21.77 | 68.42 | 62.99 | 15.39 | 11.99 | -- | 220.43 | -- | 29.27 | 13.50 | 12.01 | 29.60 | 51.98 | 28.60 | 46.14 |
| Gufic BioSciences Ltd | 8.14bn | 863.69m | 40.16bn | 1.45k | 46.04 | -- | 38.82 | 4.93 | 8.70 | 8.70 | 81.95 | -- | -- | -- | -- | 5,624,707.00 | -- | 11.46 | -- | 19.21 | 52.39 | 45.79 | 10.60 | 10.46 | -- | 8.09 | -- | 1.31 | 16.80 | 18.12 | 8.07 | 31.46 | 53.83 | 14.87 |
| SeQuent Scientific Ltd | 14.27bn | 54.87m | 43.00bn | 1.20k | 807.64 | -- | 55.35 | 3.01 | 0.2137 | 0.2137 | 57.18 | -- | -- | -- | -- | 11,939,190.00 | -- | 1.09 | -- | 1.76 | 45.38 | 41.97 | 0.9902 | 1.18 | -- | 0.9009 | -- | 35.06 | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
| Innova Captab Ltd | 11.42bn | 1.06bn | 44.28bn | -- | 32.66 | -- | 35.64 | 3.88 | 23.69 | 23.69 | 236.62 | -- | -- | -- | -- | -- | -- | 10.82 | -- | 18.38 | 33.38 | 25.18 | 9.30 | 8.04 | -- | 8.89 | -- | -- | 16.72 | 24.90 | 38.84 | 36.55 | 104.14 | -- |
| Unichem Laboratories Ltd | 17.28bn | -605.50m | 45.11bn | 3.19k | -- | -- | 86.35 | 2.61 | -8.59 | -8.59 | 245.15 | -- | -- | -- | -- | 5,410,587.00 | -- | -1.67 | -- | -2.03 | 62.00 | 56.18 | -3.50 | -3.99 | -- | 0.1401 | -- | -- | 26.94 | 7.64 | 65.15 | -- | -35.00 | -- |
| Morepen Laboratories Ltd | 17.45bn | 1.18bn | 45.91bn | 1.62k | 36.26 | -- | 30.68 | 2.63 | 2.31 | 2.31 | 34.26 | -- | -- | -- | -- | 10,749,300.00 | -- | 7.90 | -- | 13.34 | 37.86 | 33.34 | 6.77 | 5.49 | -- | 33.34 | -- | 0.00 | 19.25 | 17.08 | 148.63 | 27.22 | 47.03 | -- |
| Hikal Ltd | 18.03bn | 677.82m | 46.42bn | 2.06k | 68.52 | -- | 24.50 | 2.57 | 5.49 | 5.49 | 145.97 | -- | -- | -- | -- | 8,749,879.00 | -- | 5.07 | -- | 7.51 | 53.06 | 46.78 | 3.76 | 5.86 | -- | 2.45 | -- | 12.19 | -11.79 | 2.34 | -11.20 | -7.55 | 9.72 | 0.00 |
| Aarti Drugs Ltd | 24.23bn | 1.57bn | 47.68bn | 1.06k | 30.36 | -- | 22.80 | 1.97 | 17.08 | 17.08 | 263.82 | -- | -- | -- | -- | 22,770,740.00 | -- | 9.73 | -- | 15.78 | 34.32 | 22.23 | 6.48 | 8.25 | -- | 7.28 | -- | -- | -6.90 | 10.13 | 3.07 | 13.82 | 24.96 | -- |
| Supriya Lifescience Ltd | 5.99bn | 1.35bn | 49.03bn | 448.00 | 36.26 | -- | 32.31 | 8.19 | 16.80 | 16.80 | 74.42 | -- | -- | -- | -- | 13,370,000.00 | -- | 19.08 | -- | 24.04 | 62.75 | 57.12 | 22.58 | 24.71 | -- | 92.47 | -- | 2.88 | 23.74 | 15.47 | 32.56 | 24.75 | 83.79 | -- |
| Aarti Pharmalabs Ltd | 19.50bn | 2.25bn | 59.31bn | 1.63k | 26.32 | -- | 19.67 | 3.04 | 24.86 | 24.86 | 215.17 | -- | -- | -- | -- | 11,983,730.00 | -- | -- | -- | -- | 44.20 | -- | 11.55 | -- | -- | 18.55 | -- | -- | -4.76 | -- | 12.10 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Innova Captab Ltd's reporting currency: Indian Rupee INR
13.16%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Kotak Mahindra Asset Management Co. Ltd.as of 31 Aug 2024 | 2.21m | 3.86% |
| Canara Robeco Asset Management Co. Ltd.as of 31 Aug 2024 | 2.09m | 3.66% |
| Invesco Asset Management (India) Pvt Ltd.as of 31 Aug 2024 | 1.47m | 2.57% |
| SBI Life Insurance Co. Ltd. (Investment Portfolio)as of 30 Jun 2024 | 1.02m | 1.79% |
| Bandhan Asset Management Co. Ltd.as of 31 Aug 2024 | 321.17k | 0.56% |
| Edelweiss Asset Management Ltd.as of 31 Aug 2024 | 288.00k | 0.50% |
| WhiteOak Capital Asset Management Ltd.as of 31 Aug 2024 | 124.99k | 0.22% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Aug 2024 | 199.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 31 Aug 2024Source: FactSet Research Systems Inc.
